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ABSTRACT 
Objective: The current study emphasizes on the treatment of ocular infection with objectives of reducing the frequency of administration, obtaining 
controlled release and greater therapeutic efficacy of the drug (ofloxacin) using ocular films.  
Methods: Ocular films were designed by solvent evaporation method containing a different combination of polymers. The folding endurance 
(mechanical strength) was determined by the number of folds at a specific single place required to break the film into two parts. Thickness was 
measured using screw gauze. The surface pH was done by pH paper. The percentage moisture absorption was carried out by placing the ocular films 
in a desiccator containing ammonium chloride. Percentage moisture loss was carried out by placing the ocular films in the desiccator containing 
anhydrous calcium chloride. in vitro drug release study were carried by using a modified version of franz diffusion cell. Stability study were carried 
using stability chambers as per ICH guidelines. The antibacterial activity was performed by using male albino rabbits. 
Results: The thickness and folding endurance of the films were in the range of 44±1.1 to 92±1.8 and 4.5±0.6 to 6.8±0.3, respectively for different 
formulations. Surface pH was evaluated in the range of 6.6 to 7.2. Percentage moisture absorption and percentage moisture loss were evaluated in 
the range of 1.17±1.1 to 6.72±1.5 and 0.58±0.9 to 1.23±0.9 respectively. Microbial growth was not observed in any formulation during sterility 
testing. The drug release for different batch codes PAH, PBE, PCP, PDC, PEEH, and PFEC was found to be 96.2, 56.9, 93.4, 94.5, 98.4 and 95.9 % 
respectively up to 12 h. Ocular films of batch code PEEH was optimized for maximum drug release (98.4%). The antibacterial effect was noted 
periodically (01 to 05 d) after administration of sterile formulation in the treated eyes vs. control eyes of each rabbit. The optimized batch PEEH of 
ocular films reduced the infection and redness completely within 3 d in a single dose.  
Conclusion: The optimized formulation would be able to offer benefits such as increased residence time, prolonged drug release, reduced 
frequency of administration and improved patient compliance with complete removal of inflammation and redness from the cul-de-sac.  
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Ophthalmic liquid preparations are insufficient due to poor 
bioavailability of the drug, caused by fast lachrymal secretion and 
poor patient compliance [1]. The unique anatomy and physiology of 
the eye renders it a highly protected and sensitive organ, and the 
unique structure restricts drug entry at the target site of action. 
Conventional drug delivery systems including eye drops, 
suspensions, and ointments for the treatment of various infections 
in the cul-de-sac are frequently used, but they cannot be considered 
optimal because most topically instilled drugs do not offer adequate 
bioavailability due to the wash off of the drugs from the eye through 
lacrimation and tear dilution [2]. 
In addition, the human cornea composed of epithelium, substantia 
propria and endothelium hinders drug entry; consequently, less 
than 5% of the administered drug enters into the eye. Alternative 
approaches (ocular inserts/films, corneal shield, sol to gel system 
etc.) are continuously sought to facilitate significant drug absorption 
into the eye [3, 4]. In this ocular research films of an antibacterial 
drug (ofloxacin) was developed and evaluated for antibacterial 
response with a programmed rate for a longer period by increasing 
precorneal residence time [5]. 
The permeability of drugs through the polymeric films is dependent 
on the characteristics of the polymer, the casting solvent, and the 
plasticizers used. Plasticizers (phthalate esters, phosphate esters, 
fatty acid esters, and glycol derivatives) are very useful in the 
preparation of polymeric ocular films to reduce the brittleness, to 
impart flexibility, to increase strength, and also to improve 
adhesiveness of the films with surfaces or membranes [6]. 
To accomplish the aim of this research the predicted batches of 
ocular films of different concentration of polymer combinations 
were optimized through the factorial design study and the final 
batches were selected and developed containing hydroxyl propyl 
methyl cellulose (HPMC K100M), polyvinylpyrrolidone (PVP) and 
ethyl cellulose in the concentration of 0.5%, 0.5% and 1.0% 
respectively with polyethylene glycol (PEG 400) 10% w/w as 
plasticizer. Optimized ocular films were evaluated with various 
parameters such as folding endurance, the thickness of films, surface 
pH, percent moisture absorption, percent moisture loss, percent 
drug release, stability study, sterility testing and in vivo study [7, 8]. 
MATERIALS AND METHODS 
Materials  
Baxil Pharma Pvt. Ltd., Haridwar, India provided a gift sample of 
Ofloxacin while all the polymers of analytical grade were purchased 
from different suppliers of India like Hydroxyl Propyl Methyl 
Cellulose (HPMC K100M) from Loba Chemie Pvt. Ltd.-Mumbai, 
Polyvinylpyrrolidone (PVP) and Ethyl Cellulose from Qualikems fine 
chem. Pvt Ltd.-Delhi. Polyethylene Glycol (PEG 400) was purchased 
from Antares Chem. Pvt Ltd.-Mumbai and Arachidonic acid was 
purchased from Hi-Media Labs Pvt. Ltd., Mumbai. Microbial culture 
(Staphylococcus aureus) was purchased from Institute of Microbial 
Technology (IMTECH), Chandigarh, 06 male Albino rabbits, were 
provided by research place (animal house of R V Northland 
Institute) after IAEC protocol approval (Approval No.-
1149/PO/ac/07/CPCSEA) through CPCSEA. 
Method 
Various combinations were designed for different batches of ocular 
films as per factorial design study with 0.5 % w/v concentration by 
solvent evaporation method containing a different combination of 
polymers such as hydroxyl propyl methyl cellulose (HPMC K100M), 
ethyl cellulose, carbopol 934 and polyvinylpyrrolidone (PVP). The 
optimized concentration of selected polymers were homogenized to 
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make a clear solution. When the clear solution was prepared, 25 ml 
solution for five films was pipetted out, and the drug was added to 
the solution and homogenized with the aid of stirring. The solution 
so obtained was poured onto the glass ring placed over the 
prelubricated petri plates. One glass ring consumed 5 ml of the drug 
solution. An inverted funnel was placed over the petri plate to allow 
slow evaporation. The open end of the funnel was plugged with 
cotton wool. The whole assembly was left undisturbed till the films 
dried. After the complete drying, the film rings were lifted from the 
petri plates, and the suitable size was cut from the help of die. 
Different parameters have been evaluated for optimized ocular 
films; folding endurance, thickness, surface pH, percentage moisture 
absorption, percentage moisture loss, in vitro drug release study, 
stability study and antibacterial activity were performed with male 
albino rabbits. 
Physicochemical characterization of ocular films 
The ocular films of ofloxacin were evaluated for physicochemical 
characteristics such as folding endurance, thickness, surface pH, % 
moisture absorption, % moisture loss, stability study and % drug 
release. The folding endurance of ocular films was determined by 
the number of folds at a specific single place required to break the 
film into two parts. The thickness of the recovered films was 
measured using screw gauze [9]. After performing the initial settings 
the film was placed on the anvil such that area where the thickness 
is to be measured lies. The screw was gently tightened on to the 
specimen and reading of the gauze was noted to get the thickness of 
the film. The surface pH determination of the film was done by 
allowing them to swell by placing 2 drops of distilled water over it. 
After this the swollen film was taken and pH was determined using 
pH paper on the surface of the film [10]. 
The percentage moisture absorption test was carried out to check 
physical stability or integrity of the ocular films. Ocular films were 
weighed and placed in a desiccator containing 100 ml of saturated 
solution of ammonium chloride. After 3 d the ocular films were 
taken out and reweighed. The percentage moisture absorption was 
calculated using the formula [11]: 
 
Percentage moisture loss was carried out to check the integrity of 
the film at dry condition. Ocular films were weighed and kept in the 
desiccators containing anhydrous calcium chloride. After 3 d the 
ocular films were taken out and reweighed, the percentage moisture 
loss was calculated using the formula [12]: 
 
In vitro drug release study 
The inserts were placed on a modified version of Franz diffusion cell 
using cellophane membrane in contact with isotonic phosphate 
buffer pH 7.4 kept at 37±1 °C with constant stirring of 50 rpm. 1 ml 
Sample was withdrawn at different time intervals analyzed for drug 
content spectrophotometrically (Shimadzu UV 1700) at 294 nm [13, 
14]. 
Stability study of optimized batch of ocular film 
Stability studies were carried out on batch code PEEH, according to 
ICH guidelines by storing replicates of ocular films (packaged in 
aluminium foil) for a period of 0, 30, 90 and 180 d with a relative 
humidity 75%±5% at a temperature 40 °±2 °C and 180 d at room 
temperature using the stability chamber. The sample was collected 
after 30, 90, 180 d under accelerated conditions and 180 d at RT, 
respectively and evaluated [15, 16]. 
Sterility testing of optimized batch of ocular film 
Sterility tests were based on the principle that if bacteria of fungi are 
placed in a medium having moisture and the desired pH and kept at 
a favorable temperature, the organism will grow and their presence 
can be indicated by the growth in originally medium [17]. Optimized 
batch of ocular films was taken in two different sterile nutrient agar 
petri dishes. One uninoculated nutrient agar petri dish was taken as 
a negative control (to test sterility of the medium). A lab isolated 
culture of Staphylococcus aureus was inoculated in one nutrient agar 
petri dish served as positive control. Both the petri dishes were 
incubated at 37 °C for 24 h. Results were interpreted with positive 
and negative control petri dishes. The growth of microorganism was 
observed in positive control and no growth of microorganisms was 
observed in the negative control test, which confirmed that all the 
apparatus used for the test were sterile and aseptic conditions were 
maintained. Now the sample formulation was placed in the negative 
control test and incubated at same conditions. There was no growth 
of a microorganism in the samples under test, confirming the 
sterility of ocular films. These sterile ocular films were considered 
suitable for in vivo studies [18-20]. 
Sterilization of optimized batch of ocular film 
These formulations were sterilized separately by exposing both 
sides to UV radiation for 90 min in a cabinet under aseptic 
conditions and were finally packaged in pre-sterilized aluminium 
foil [21]. 
In vivo study 
The protocol for in vivo 
RESULTS AND DISCUSSION 
studies in rabbit was designed and approved 
by institutional animal ethics committee of research place. The 
rabbits were fed balanced diet pellets and maintained in a 
temperature-controlled room, at 20 °C to 24 °C before the 
experiment. The antibacterial activity (redness in conjunctiva and 
zone of inhibition for microbial growth) was carried with all 06 
rabbits eyes divided into two groups (left eyes as a positive control 
group and right eyes as treated group). A microbial culture of 
Staphylococcus aureus 10 µl was instilled into both groups in each 
rabbit and incubated at room temperature in an aseptic room of 
microbiology lab for 24 h. The redness and infection in both groups 
in each rabbit were observed, and treatment was started after 24 h 
up to 5 d with the administration of sterile ocular inserts containing 
ofloxacin only in treated groups per day.  
Redness was scored as follows: 0= Normal; 1= mild redness; 2= 
moderate redness; and 3= fully red conjunctiva. With this test, zone 
of inhibition was also observed for the treated group. Fresh sterile 
nutrient agar petri dishes were prepared and incubated for 24 h 
with test organism (S. aureus culture) at 37 °C. The fluid tear 
samples from the treated group were collected at an interval of 2 h 
with the help of a sterile swab up to 12 h. These swabs (containing 
released drug from ocular films) were placed on petri dishes of test 
organism over 24 h and the zone of inhibition were calculated 
separately with the help of Image-J software [22, 24]. 
The ocular films of ofloxacin were prepared by a solvent evaporation 
method using glycerin as a lubricant and characterized on the bases 
of physicochemical parameters, sterility testing, in vitro and in vivo 
release studies. All the formulations with each polymer were 
evaluated for various parameters such as folding endurance, 
thickness, surface pH, % moisture absorption, % moisture loss, drug 
release of ofloxacin (table 1). The nature of rate-controlling 
membrane had influences on the physicochemical characteristics of 
the ocular films. The plasticizer is the most important component 
which may affects the mechanical properties of the films by lowering 
the glass-transition temperature of the polymer.  
In this study, polyethylene glycol (PEG-400) at a concentration of 
10% w/w of total polymer was selected since it gave sufficiently 
pliable films to allow for uniform subdivision into films without 
breaking the film. Ocular films of hydroxyl propyl methyl cellulose 
(HPMC K100M) with rate-controlling membranes of ethyl cellulose 
(EC) and polyvinylpyrrolidone (PVP) were flexible and elastic. 
Thickness and folding endurance were optimum in all batches and 
the % cumulative drug release (table 2) was evaluated with all six 
batches, the batch code PEEH was optimized with a maximum drug 
release (98.4±1.1) having surface pH (7.2), % moisture absorption 
(2.97±1.1w/w) and % moisture loss (0.58±0.9 w/w). 
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Table 1: in vitro evaluation of optimized batches 
Batch code Thickness (µm) Folding endurance 
(no. of  folds) 
Surface pH % Moisture 
absorption (w/w) 
% moisture loss 
(w/w) 
% Drug release 
 
PAH 5.6±0.2 73±1.2  6.9 6.72±1.5 1.02±0.8 96.2±0.9 
PBE 4.6±0.1 92±1.8 7.1 1.17±1.1 0.58±1.7 56.9±1.2 
PCP 6.8±0.3 47±0.9 6.6 4.88±1.2 0.98±1.0 93.4±1.2 
PDC 6.3±0.2 44±1.1 7.1 6.15±1.6 1.23±0.9 94.5±1.1 
PEEH 4.9±0.2 82±1.1 7.2 2.97±1.1 0.58±0.9 98.4±1.1 
PFEC 4.5±0.6 48±0.7 7.1 3.04±1.2 0.69±1.8 95.9±0.9 
Values are expressed as mean±SD (n=5) 
 
Table 2: % cumulative release of optimized batches of ocular films of ofloxacin 
Time (h) PAH PBE PCP PDC PEEH PFEC 
0.5 9.14 8.06 6.03 9.10 9.70 6.00 
1 18.07 13.36 15.02 16.10 11.09 15.76 
1.5 27.02 19.61 25.66 23.10 28.83 22.20 
2 34.10 24.05 39.91 33.11 34.78 32.65 
3 45.32 25.69 45.08 40.26 47.86 45.66 
4 50.95 32.76 48.79 55.88 55.22 48.96 
5 65.15 37.00 61.86 64.60 59.86 58.72 
6 73.18 42.91 74.57 72.63 67.83 73.62 
7 80.51 45.41 75.46 77.13 81.27 76.85 
8 83.97 48.29 83.02 85.59 88.08 85.25 
10 90.62 53.51 88.94 92.64 94.46 91.87 
12 96.20 56.90 93.40 94.50 98.40 95.90 
 
Stability study 
On the bases of physicochemical characteristics and in vitro 
comparative release study of all six batches, the stability study was 
performed for batch code PEEH with accelerated study from 0 d to 6 
mo and up to 6 mo with room temperature and the folding 
endurance, thickness, surface pH, % moisture absorption (table 3) 
and % drug release (table 4) were further evaluated. From the 
accelerated stability studies, performed at elevated temperature and 
humidity revealed that no significant changes were observed in film 
thickness, folding endurance and surface pH [25]. Ocular films could 
be stored safely at study storage conditions. However, storage 
temperature not in excess of 40 °C and moisture-proof packing are 
recommended to ensure the stability of the formulation. Overall the 
degradation was less than 5%, a tentative shelf-life of more than 
years may be assigned to the formulations as per the ICH guidelines.
 
Table 3: stability study of final selected batch PEEH 
Parameters evaluated Accelerated study Room temp. 
0 d 30 d 90 d 180 d 180 d 
Folding endurance 82 81 78 75 81 
Thickness (µm) 4.9 4.9 4.9 4.8 4.9 
Surface pH 7.2 7.2 7.2 7.3 7.2 
% moisture Absorption (w/w) 2.97 3.09 3.18 3.33 2.99 
% Drug Release 96.90 95.43 94.63 93.87 95.89 
 




Accelerated study  Room temp. 
0 d 30 d 90 d 180 d  180 d 
0.5 5.99 5.42 6.76 5.37 7.38 
1 15.76 14.25 11.30 8.35 9.46 
1.5 22.20 16.98 19.35 17.22 18.92 
2 32.65 28.86 26.88 22.04 27.73 
3 45.66 37.46 41.38 39.56 35.41 
4 48.96 46.52 46.78 46.73 46.76 
5 58.72 48.32 52.93 56.25 55.39 
6 73.62 59.13 60.10 67.63 68.19 
7 76.85 73.53 74.86 76.84 73.45 
8 85.25 85.59 82.08 84.58 82.12 
10 91.87 92.64 90.14 90.35 89.61 
12 96.90 95.43 94.63 93.87 95.89 
 
In vivo study 
Redness in conjunctiva was noted periodically (01 to 05 d) in both 
eyes of each animal after administration of predicted sterile 
formulation in the treated eyes vs. control eyes [26]. One-way 
ANOVA, followed by Tukey-Kramer multiple comparison test were 
used for comparison of the means of different groups [27]. There is a 
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significant decrease (P<0.01 and P<0.001) in scores of redness as 
compared with positive control group. As per the data shows in the 
(table 5) the predicted batch PEEH of ocular inserts reduced the 
redness completely up to 4th day dose. 
 




1 2 3 4 5 
Control (Left eye) 2.666±0.210 3±0 2.833±0.166 3±0 3±0 
Treated (Right eye) 1.833**±0.166 0.833***±0.166 0.333***±0.210 0***±0 0***±0 
(** P<0.01, ***P<0.001 vs. control group) 
 
Zone of inhibition study 
The bacterial load was noted periodically (02 to 12 h) in treated eyes of 
each animal after administration of predicted sterile formulation in the 
treated eyes vs. control eyes. One-way ANOVA, followed by Tukey-
Kramer multiple comparison tests was used for comparison of the 
means of different groups. There is a significant difference (P<0.001) in 
the diameter area of zone of inhibition as compared with positive control 
group. The data shows in the (table 6) the samples were withdrawn 
from the treated groups of a predicted batch of ocular inserts reduced 
the maximum bacterial load as per standard test (ciprofloxacin CF30 
susceptibility test disc were used for in vitro standard test). 
 
Table 6: Effect of the anti-bacterial response of predicted batch PEEH with zone of inhibition (Avg. mean of area in mm2
Group (Avg.±sem) 
) 
Diameter in mm2 of zone of inhibition with time (hrs) 
2 4 6 8 10 12 
Treated (Right eye) 9.5±0.619 15.5±1.056 21.666±0.802 23.166±0.307 23.5±0.223 23.833±0.307 
(***P<0.001 vs. control group) 
 
CONCLUSION 
Ocular films of ofloxacin prepared by a solvent evaporation method 
using a good film-forming hydrophilic polymer hydroxyl propyl 
methyl cellulose (HPMC K100M) with a satisfactory rate controlling 
membranes of ethyl cellulose (EC) and polyvinylpyrrolidone (PVP) 
included polyethylene glycol (PEG 400) as a plasticizer. Various 
concentrations were designed with different combinations but the 
concentration of batch code PEEH was smooth, flexible and 
transparent. Physicochemical parameters viz folding endurance, 
thickness, surface pH, percentage moisture absorption, percentage 
moisture loss, stability study, sterility testing were in optimum range 
for optimized batch of ocular film. in vitro and in vivo study revealed 
that the optimized formulation would be able to offer benefits such as 
increased residence time, prolonged drug release, reduced frequency 
of administration and improved patient compliance with complete 
removal of inflammation and redness from the cul-de-sac.  
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